Australian Biotechnology News
Latest stories
  • +

    Lorne special: Dynamic dynamin and synaptic transmission 09/02/2010 11:18:00

    Dynamin-1, plays a key role in the endocytosis at the synapse and the activity of neurotransmitters. Professor Phil Robinson is revealing the behaviour of this pivotal protein and its role in diseases like epilepsy.
    Dynamin-1, plays a key role in the endocytosis at the synapse and the activity of neurotransmitters. Professor Phil Robinson is revealing the behaviour of this pivotal protein and its role in diseases like epilepsy.
  • +

    BioProspect a step closer to commercialising natural anti-termite repellent 08/02/2010 13:01:00

    APVMA registers Erimophilone Oil as an active ingredient, end-user product could be available within two years.
    APVMA registers Erimophilone Oil as an active ingredient, end-user product could be available within two years.
  • +

    Australian biotech market watch 05/02/10 05/02/2010 11:45:00

    CSL, ResMed, Living Cell Technology, Mesoblast, Prima BioMed, Sirtex Medical, CathRx
    CSL, ResMed, Living Cell Technology, Mesoblast, Prima BioMed, Sirtex Medical, CathRx
  • +

    Another malaria breakthrough offers potential drug target 04/02/2010 11:09:00

    Researchers at the WEHI have identified a protein that could present an attractive drug target to prevent the parasite's spread through the blood.
    Researchers at the WEHI have identified a protein that could present an attractive drug target to prevent the parasite's spread through the blood.
  • +

    Lorne special: Cell polarity and the T-cell 03/02/2010 12:29:00

    A collaborative venture between Sarah Russell at Peter Mac and microscopists at Swinbourne University of Technology is yielding insights into the behaviour of T cells.
    A collaborative venture between Sarah Russell at Peter Mac and microscopists at Swinbourne University of Technology is yielding insights into the behaviour of T cells.
  • +

    Australian biotech market watch 02/02/10 02/02/2010 15:42:00

    CathRX, Mesoblast, ChemGenex, Living Cell Technologies, QRxPharma, CSL, ResMed, Cochlear
    CathRX, Mesoblast, ChemGenex, Living Cell Technologies, QRxPharma, CSL, ResMed, Cochlear
More >AgBiotech
More >Biomedical
  • +

    Promising anti-malaria target found 01/02/2010 12:12:00

    Australian and international researchers identify an enzyme that could prove an effective anti-malaria drug target.
    Australian and international researchers identify an enzyme that could prove an effective anti-malaria drug target.
  • +

    Starpharma and Lilly sign new drug delivery collaboration 01/02/2010 11:48:00

    Lilly to use Starpharma's dendrimer drug delivery technology for human pharmaceuticals.
    Lilly to use Starpharma's dendrimer drug delivery technology for human pharmaceuticals.
More >Bioinformatics
  • +

    Australian Life Scientist January-February edition on sale now! 25/01/2010 17:23:00

    Lorne proteins, genome and cancer, cloud computing special, diagnosing Darwin's disease and more.
    Lorne proteins, genome and cancer, cloud computing special, diagnosing Darwin's disease and more.
  • +

    Soybean genome sequenced 14/01/2010 11:34:00

    Complete genome expected to lead to improved strains of this vital economic crop.
    Complete genome expected to lead to improved strains of this vital economic crop.
Additional Resources
Newsletter Subscription
Sign up for our Australian Life Scientist newsletters!
Subscribe now!
 
Jobs
Sponsored Links